100 related articles for article (PubMed ID: 23236681)
1. [Jangee – young, free and beautiful].
Velev P
Akush Ginekol (Sofiia); 2012; 51 Suppl 1():47. PubMed ID: 23236681
[No Abstract] [Full Text] [Related]
2. Hormonal contraceptives for acne management.
Rich P
Cutis; 2008 Jan; 81(1 Suppl):13-8. PubMed ID: 18338653
[TBL] [Abstract][Full Text] [Related]
3. Ethinyl estradiol/drospirenone (Yasmin): a newer oral contraceptive.
Somma MA
Am Fam Physician; 2004 May; 69(10):2425-6. PubMed ID: 15168965
[No Abstract] [Full Text] [Related]
4. Estradiol + nomegestrol. Oral contraceptive claimed to be more natural, but presenting no obvious advantages.
Prescrire Int; 2012 Dec; 21(133):292. PubMed ID: 23373095
[TBL] [Abstract][Full Text] [Related]
5. Drospirenone: a novel progestin.
Rapkin AJ; Winer SA
Expert Opin Pharmacother; 2007 May; 8(7):989-99. PubMed ID: 17472544
[TBL] [Abstract][Full Text] [Related]
6. Contraceptive efficacy of a combined oral contraceptive containing ethinyloestradiol 20 μg/drospirenone 3mg administered in a 24/4 regimen: a pooled analysis of four open-label studies.
Anttila L; Bachmann G; Hernádi L; Kunz M; Marr J; Klipping C
Eur J Obstet Gynecol Reprod Biol; 2011 Apr; 155(2):180-2. PubMed ID: 21277674
[TBL] [Abstract][Full Text] [Related]
7. Treatment of moderate acne vulgaris using a combined oral contraceptive containing ethinylestradiol 20 μg plus drospirenone 3mg administered in a 24/4 regimen: a pooled analysis.
Koltun W; Maloney JM; Marr J; Kunz M
Eur J Obstet Gynecol Reprod Biol; 2011 Apr; 155(2):171-5. PubMed ID: 21288628
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of a new oral contraceptive containing drospirenone and ethinyl estradiol in the long-term treatment of hirsutism.
Batukan C; Muderris II
Fertil Steril; 2006 Feb; 85(2):436-40. PubMed ID: 16595223
[TBL] [Abstract][Full Text] [Related]
9. 17-Hydroxysteroid dehydrogenase type 5 gene polymorphism (-71A/G HSD17B5 SNP) and treatment with oral contraceptive pills in PCOS women without metabolic comorbidities.
Maier PS; Mattiello SS; Lages L; Spritzer PM
Gynecol Endocrinol; 2012 Aug; 28(8):606-10. PubMed ID: 22329763
[TBL] [Abstract][Full Text] [Related]
10. Cyproterone acetate or drospirenone containing combined oral contraceptives plus spironolactone or cyproterone acetate for hirsutism: randomized comparison of three regimens.
Kelekci KH; Kelekci S; Yengel I; Gul S; Yilmaz B
J Dermatolog Treat; 2012 Jun; 23(3):177-83. PubMed ID: 21254871
[TBL] [Abstract][Full Text] [Related]
11. A randomized controlled trial of a low-dose combined oral contraceptive containing 3 mg drospirenone plus 20 microg ethinylestradiol in the treatment of acne vulgaris: lesion counts, investigator ratings and subject self-assessment.
Maloney JM; Dietze P; Watson D; Niknian M; Lee-Rugh S; Sampson-Landers C; Korner P
J Drugs Dermatol; 2009 Sep; 8(9):837-44. PubMed ID: 19746676
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and tolerance of acne treatment using both spironolactone and a combined contraceptive containing drospirenone.
Krunic A; Ciurea A; Scheman A
J Am Acad Dermatol; 2008 Jan; 58(1):60-2. PubMed ID: 17964689
[TBL] [Abstract][Full Text] [Related]
13. Triphasil--a new triphasic oral contraceptive.
Med Lett Drugs Ther; 1985 May; 27(688):48. PubMed ID: 4000059
[No Abstract] [Full Text] [Related]
14. Comparison of scales for evaluating premenstrual symptoms in women using oral contraceptives.
Coffee AL; Kuehl TJ; Sulak PJ
Pharmacotherapy; 2008 May; 28(5):576-83. PubMed ID: 18447656
[TBL] [Abstract][Full Text] [Related]
15. Premenstrual syndrome.
Helmerhorst FM; Lopez LM; Kaptein AA
Lancet; 2008 Aug; 372(9637):446; author reply 446-7. PubMed ID: 18692709
[No Abstract] [Full Text] [Related]
16. Effect of oral contraceptive containing ethinyl estradiol combined with drospirenone vs. desogestrel on clinical and biochemical parameters in patients with polycystic ovary syndrome.
Kriplani A; Periyasamy AJ; Agarwal N; Kulshrestha V; Kumar A; Ammini AC
Contraception; 2010 Aug; 82(2):139-46. PubMed ID: 20654754
[TBL] [Abstract][Full Text] [Related]
17. Oral contraceptives and premenstrual symptoms: comparison of a 21/7 and extended regimen.
Coffee AL; Kuehl TJ; Willis S; Sulak PJ
Am J Obstet Gynecol; 2006 Nov; 195(5):1311-9. PubMed ID: 16796986
[TBL] [Abstract][Full Text] [Related]
18. Clinical experiences with drospirenone: from reproductive to postmenopausal years.
Pérez-López FR
Maturitas; 2008 Jun; 60(2):78-91. PubMed ID: 18468818
[TBL] [Abstract][Full Text] [Related]
19. Treatment of acne using a 3-milligram drospirenone/20-microgram ethinyl estradiol oral contraceptive administered in a 24/4 regimen: a randomized controlled trial.
Maloney JM; Dietze P; Watson D; Niknian M; Lee-Rugh S; Sampson-Landers C; Korner P
Obstet Gynecol; 2008 Oct; 112(4):773-81. PubMed ID: 18827119
[TBL] [Abstract][Full Text] [Related]
20. Mircette: a novel oral contraceptive. Introduction.
Speroff L
Am J Obstet Gynecol; 1998 Jul; 179(1):S1. PubMed ID: 9704811
[No Abstract] [Full Text] [Related]
[Next] [New Search]
